Benin vs Indonesia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Benin
0.7%
in 2024
Indonesia
0.7%
in 2024
Benin rank
43rd
Indonesia rank
43rd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Benin
- Indonesia
How they compare
Benin currently reports 0.7% against 0.7% in Indonesia, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Indonesia ahead.
Benin ranks 43rd and Indonesia ranks 43rd of 215 countries.
Benin has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Benin | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.0% | 0.9% | 0.1% | Benin |
| 2020s | 0.9% | 0.8% | 0.0% | Benin |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Benin or Indonesia?
- Benin, at 0.7% against 0.7% in Indonesia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Benin and Indonesia?
- 0.0%, with Benin ahead.
- How many years of comparable data are there for Benin and Indonesia?
- 10 years are reported by both, from 2015 to 2024.
- How do Benin and Indonesia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Benin ranks 43rd and Indonesia ranks 43rd of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.